The Supreme Court has temporarily allowed access to the abortion pill mifepristone via mail for at least three more days. This ruling is significant for individuals seeking medication abortions, as it continues to provide an alternative to in-person visits amidst ongoing legal challenges to telehealth prescribing. The process of obtaining the abortion pill by mail involves patients connecting with healthcare providers through telemedicine. If eligible, providers can prescribe mifepristone, which can then be mailed to the patient's home or sent to a local pharmacy for pickup. This method streamlines access to necessary healthcare services, particularly for those in remote areas. Key benefits of receiving the abortion pill by mail include increased accessibility for patients who might otherwise face difficulties traveling to clinics, enhanced privacy, and the convenience of receiving medication discreetly at home. Telemedicine has played a crucial role in expanding access to abortion services, notably contributing to an increase in the number of medication abortions across the U.S. since the Supreme Court overturned Roe v. Wade. However, there are limitations to consider, such as potential legal restrictions in certain states that may impose strict regulations on mail-order prescriptions. Additionally, not all patients may qualify for a medication abortion due to specific health conditions, which can affect their access to this service.